Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis - Association and Prediction

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Løken Amsrud, Kristin I ^a,b   Myhr, Kjell Morten ^c,d   Bakke, Søren J ^e   Beiske, Antonie G ^f   Bjerve, Kristian S ^g,h   Bjørnarå, Bård T ⁱ   Hovdal, Harald ^g   Lilleås, Finn ^j   Midgard, Rune ^h,k   Pedersen, Tom ^l   Benth, Jurate Šaltyte ^b,m   Torkildsen, Øivind ^c   Wergeland, Stig ^c   Holmøy, Trygve ^b,m  

^a INNLANDET HOSPITAL TRUST   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f Multiple Sclerosis Centre Hakadal   (Norway)

^g TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^h NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

ⁱ Helsehuset Kongsberg   (Norway)

^j Curato Oslo   (Norway)

^k Molde Hospital   (Norway)

^l Unilabs   (France)

^m AKERSHUS UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA1A INTERFERON; DOCOSAHEXAENOIC ACID; HLA DRB1 ANTIGEN; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; PLACEBO; PROSTAGLANDIN E2; TRIOMAR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; EXPANDED DISABILITY STATUS SCALE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEASONAL VARIATION; SEX DIFFERENCE; VITAMIN BLOOD LEVEL;

ADULT; ALPHA-TOCOPHEROL; COHORT STUDIES; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HLA-DRB1 CHAINS; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84872768884     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054417     Document Type: Article

References (32)

1. Garcia-Closas R, Berenguer A, Tormo MJ, Sanchez MJ, Quiros JR, et al. (2004) Dietary sources of vitamin C, vitamin E and specific carotenoids in Spain. Brit J Nutr 91: 1005-1011.
2. Zingg JM, Azzi A, (2004) Non-Antioxidant Activities of Vitamin E. Curr Med Chem. 11: 1113-1133.
3. Pekmezci D, (2011) Vitamin E and Immunity. Vitam Horm 86: 179-215.
4. Lassmann H, van Horssen J, (2011) The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett 585: 3715-3723.
5. Sheridan PA, Beck MA, (2009) The dendritic and T cell responses to herpes simplex virus-1 are modulated by dietary vitamin E. Free Radic Biol Med. 46: 1581-1588.
6. Heppner FL, Roth K, Nitsch R, Hailer NP, (1998) Vitamin E induces ramification and downregulation of adhesion molecules in cultured microglial cells. Glia 22: 180-188.
7. Goudarzvand M, Javan M, Mirnajafi-Zadeh J, Mozafari S, Tiraihi T, (2010) Vitamins E and D3 Attenuate Demyelination and Potentiate Remyelination Processes of Hippocampal Formation of Rats Following Local Injection of Ethidium Bromide. Cell Mol Neurobiol 30: 289-299.
8. Hsieh CC, Lin BF, (2005) Opposite effects of low and high dose supplementation of vitamin E on survival of MRL/lpr mice. Nutrition 21: 940-948.
9. Karg E, Klivenyi P, Nemeth I, Bencsik K, Pinter S, et al. (1999) Nonenzymatic antioxidants of blood in multiple sclerosis. J Neurol 246: 533-539.
10. Karg E, Klivenyi P, Bencsik K, Turi S, Vecsei L, (2003) Alpha-Tocopherol and NADPH in the Erythrocytes and Plasma of Multiple Sclerosis Patients. Eur Neurol 50: 215-219.
11. Torkildsen O, Wergeland S, Bakke S, Beiske AG, Bjerve KS, et al. (2012) Omega-3 Fatty Acid Treatment in Multiple Sclerosis (OFAMS study): a randomised, double-blind, placebo-controlled trial. Arch Neurol. 69: 1044-1051 DOI:10.1001/archneurol.2012.283.
12. Løken-Amsrud KI, Holmøy T, Bakke SJ, Beiske AG, Bjerve KS, et al. (2012) Vitamin D and disease activity in multiple sclerosis before and during interferon beta treatment. Neurology 79: 267-273.
13. Løken-Amsrud KI, Myhr KM, Bakke SJ, Beiske AG, Bjerve KS, et al. (2012). Retinol levels are associated eith magnetic resonance imaging outcomes in multiple sclerosis. Mult Scler J. Epub ahead of print 20 August DOI:10.1177/1352458512457843.
14. Al-Azemi MK, Omu AE, Fatinikun T, Mannazhath N, (2009) Factors contributing to gender differences in serum retinol and alpha-tocopherol in infertile couples. Reprod Bio Med Online 19: 583-590.
15. Hedström AK, Sundqvist E, Bäärnhielm M, Nordin N, Hillert J, et al. (2011) Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 134: 653-664.
16. Mehta LR, Dworkin RH, Schwid SR, (2009) Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis. Nat Clin Pract Neurol 5: 82-92.
17. Simpson JL, Bailey LB, Pietrzik K, Shane B, Holzgreve W, (2010) Micronutrients and women of reproductive potential: required dietary intake and consequences of dietary deficienty or excess. Part II- Vitamin D, Vitamin A, Iron, Zinc, Iodine, Essential Fatty Acids. J Matern Fetal Neonatal Med 24: 1-24.
18. Salemi G, Gueli M, Vitale F, Battaglieri F, Guglielmini E, et al. (2010) Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients. Lipids Health Dis 9: 19-21.
19. Besler HT, Comoglu S, Okcu Z, (2002) Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis. Nutr Neurosci 5: 215-220.
20. Jimenez-Jimenez FJ, de Bustos F, Molina JA, de Andrés C, Gasalla T, et al. (1998) Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis. Neurosci Lett 249: 65-67.
21. Zhang SM, Hernan MA, Olek MJ, Spiegelman D, Willett WC, et al. (2001) Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women. Neurology 57: 75-80.
22. Jarvinen R, (1995) Carotenoids, retinoids, tocopherols and tocotrienols in the diet; the Finnish Mobile Clinic Health Examination Survey. Int J Vitam Nutr Res 65: 24-30.
23. Becker W, Lyhne N, Pedersen AN, Aro A, Fogelholm M, et al. (2004) Nordic Nutrition Recommendations 2004- integrating nutrition and physical activity. Scandinavian Journal of Nutrition 48: 178-187.
24. Bjornson LK, Kayden HJ, Miller E, Moshell AN, (1976) The transport of alpha-tocopherol and beta-carotene in human blood. J Lipid Res 17: 343-352.
25. Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, et al. (2011) Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation 8: 127.
26. Venkatraman JT, Chu Wc, (1999) Effects of Dietary omega-3 and omega-6 Lipids and Vitamin E on Serum Cytokines, Lipid Mediators and Anti-DNA Antibodies in a Mouse Model for Rheumatoid Arthritis. J Am Coll Nutr 18: 602-613.
27. Ruuls SR, Bauer J, Sontrop K, Huitinga I, 't Hart BA, et al. (1995) Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol 56: 207-217.
28. Bø L, Dawson TM, Wesselingh S, Mørk S, Choi S, et al. (1994) Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 36: 778-786.
29. Vladimirova O, O'Connor J, Cahill A, Alder H, Butunoi C, et al. (1998) Oxidative damage to DNA in plaques of MS brains. Mult Scler 4: 413-418.
30. Saarela J, Kallio SP, Chen D, Montpetit A, Jokiaho A, et al. (2006) PRKCA and Multiple Sclerosis: Association in Two Independent Populations. PLoS Genet 2(3): e42.
31. Vladimirova O, Lu FM, Shawver L, Kalman B, (1999) The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls. Inflamm Res 48: 412-416.
32. Lucas M, Rodriüguez MC, Gata JM, Zayas MD, Solano F, et al. (2003) Regulation by interferon beta-1a of reactive oxygen metabolites production by lymphocytes and monocytes and serum sulfhydryls in relapsing multiple sclerosis patients. Neurochem Int 42: 67-71.